Led by professionals with scientific and biotech-specific finance backgrounds, Ikarian Capital selects companies involved in cutting-edge science and strong business fundamentals, regardless of indication, market cap, or geography. Leveraging their co-founder's medical and financial expertise, they invest in biotechnology and pharmaceuticals through both long and short positions.